BDNF gene expression association with suicide and psychiatric disorders in children and adolescents: (Relationship between BDNF gene expression and suicide).


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
23 07 2021
Historique:
received: 27 10 2020
revised: 01 04 2021
accepted: 05 05 2021
pubmed: 11 5 2021
medline: 29 1 2022
entrez: 10 5 2021
Statut: ppublish

Résumé

In the current study, it was aimed to investigate the relationship between BDNF gene expression and childhood suicide attempt, childhood traumatic experiences, and problem-solving skills in children and adolescents. The suicide group consisted of 100 children and adolescents aged 11-18 years who were referred to our outpatient department due to suicide attempt. For further comparisons, 100 children and adolescents who have no any psychiatric diagnosis were referred to our same outpatient department were selected. A sociodemographic data form, the Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime version (K-SADS-PL), the Suicide Intent Scale (SIS), Problem Solving Inventory (PSI), and the Childhood Trauma Questionnaire (CTQ) were used for both groups. Total RNA was isolated from whole blood samples and BDNF gene expression levels were measured using quantitative real time-polymerase chain reaction (QRT-PCR). The total and subscale scores of the PSI and CTQ were found to be significantly higher in the suicide group than in the control group. There was no significant difference between the groups in terms of BDNF gene expression levels. However, gene expression of BDNF was found significantly increased in patients who have any psychiatric disorder compared with the others. Our results indicate that BDNF gene expression could be more associated with psychiatric disorders rather than suicide attempt in children and adolescents.

Identifiants

pubmed: 33971247
pii: S0166-4328(21)00238-2
doi: 10.1016/j.bbr.2021.113350
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
BDNF protein, human 7171WSG8A2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113350

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Rabia Yilmaz (R)

Kilis State Hospital, Department of Child and Adolescent Psychiatry, Kilis, Turkey.

Didem Behice Öztop (DB)

Ankara University, Faculty of Medicine, Department of Child and Adolescent Psychiatry, Ankara, Turkey.

Elif Funda Sener (EF)

Erciyes University, Faculty of Medicine, Department of Medical Biology, Kayseri, Turkey.

Merve Cikili-Uytun (M)

Ankara University, Faculty of Medicine, Department of Child and Adolescent Psychiatry, Ankara, Turkey. Electronic address: merveuytun@gmail.com.

Fatma Dal (F)

Erciyes University, Faculty of Medicine, Genom and Stem Cell Center, Kayseri, Turkey.

Emrah Yildiz (E)

Kilis State Hospital, Department of Psychiatry, Kilis, Turkey.

Musa Sahpolat (M)

Kilis State Hospital, Department of Psychiatry, Kilis, Turkey.

Gokmen Zararsiz (G)

Erciyes University, Faculty of Medicine, Department of Biostatistics, Kayseri, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH